| Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ... Annals of the rheumatic diseases 74 (6), 1087-1093, 2015 | 202 | 2015 |
| Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. HKL Low AS, Symmons DP, Lunt M, Mercer LK, Gale CP, Watson KD, Dixon WG Annals of Rheumatic Disease 76 (4), 654-660, 2017 | 161 | 2017 |
| Is knee osteoarthritis a symmetrical disease? Analysis of a 12 year prospective cohort study AJ Metcalfe, MLE Andersson, R Goodfellow, CA Thorstensson BMC musculoskeletal disorders 13, 1-8, 2012 | 156 | 2012 |
| Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population LK Mercer, R Davies, JB Galloway, A Low, M Lunt, WG Dixon, KD Watson, ... Rheumatology 52 (1), 91-98, 2013 | 150 | 2013 |
| Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis LK Mercer, JB Galloway, M Lunt, R Davies, ALS Low, WG Dixon, ... Annals of the rheumatic diseases 76 (3), 497-503, 2017 | 130 | 2017 |
| A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis AS Williams, JP Camilleri, RM Goodfellow, BD Williams Rheumatology 35 (8), 719-724, 1996 | 124 | 1996 |
| Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis PJ Richards, AS Williams, RM Goodfellow, BD Williams Rheumatology 38 (9), 818-825, 1999 | 121 | 1999 |
| Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome D Beroukas, R Goodfellow, J Hiscock, R Jonsson, TP Gordon, ... Laboratory investigation 82 (2), 203-210, 2002 | 117 | 2002 |
| The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology … L Silva-Fernández, M Lunt, L Kearsley-Fleet, KD Watson, WG Dixon, ... Rheumatology 55 (11), 2033-2039, 2016 | 101 | 2016 |
| Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen‐induced arthritis RM Goodfellow, AS Williams, JL Levin, BD Williams, BP Morgan Clinical & Experimental Immunology 119 (1), 210-216, 2000 | 96 | 2000 |
| Interferon-γ inhibits interleukin-1β-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis CE Page, S Smale, SM Carty, N Amos, SN Lauder, RM Goodfellow, ... Arthritis research & therapy 12, 1-10, 2010 | 84 | 2010 |
| Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono‐articular arthritis RM Goodfellow, AS Williams, JL Levin, BD Williams, BP Morgan Clinical & Experimental Immunology 110 (1), 45-52, 1997 | 78 | 1997 |
| Interferon‐γ protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints AS Williams, PJ Richards, E Thomas, S Carty, MA Nowell, RM Goodfellow, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 76 | 2007 |
| Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity KL Hyrich, C Deighton, KD Watson, BSRBR Control Centre Consortium, ... Rheumatology 48 (10), 1323-1327, 2009 | 62 | 2009 |
| The effects of functional suppression of a membrane‐bound complement regulatory protein, CD59, in the synovial tissue in rats M Mizuno, K Nishikawa, RM Goodfellow, SJ Piddlesden, BP Morgan, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 51 | 1997 |
| The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations A Williams, R Goodfellow, N Topley, N Amos, B Williams Inflammation Research 49, 155-161, 2000 | 40 | 2000 |
| The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA J Závada, M Lunt, R Davies, ASL Low, LK Mercer, JB Galloway, ... Annals of the rheumatic diseases 73 (1), 252-255, 2014 | 34 | 2014 |
| British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) and the BSRBR Control Centre Consortium. Relationship between exposure to tumour … AS Low, DP Symmons, M Lunt, LK Mercer, CP Gale, KD Watson, ... Ann Rheum Dis 76 (4), 654-660, 2017 | 31 | 2017 |
| Interleukin‐1β (IL‐1β) inhibition: a possible mechanism for the anti‐inflammatory potency of liposomally conjugated methotrexate formulations in arthritis AS Williams, SG Jones, RM Goodfellow, N Amos, BD Williams British journal of pharmacology 128 (1), 234-240, 1999 | 28 | 1999 |
| Nonserious infections in patients with rheumatoid arthritis: results from the British Society for rheumatology biologics register for rheumatoid arthritis K Bechman, K Halai, M Yates, S Norton, AP Cope, ... Arthritis & Rheumatology 73 (10), 1800-1809, 2021 | 22 | 2021 |
